FDA.reportPublic FDA data

donislecel-jujn 400 ML Injection

RxCUI
2642264
RxNorm name
donislecel-jujn 400 ML Injection
Display name
donislecel-jujn 400 ML Injection
Full name
donislecel-jujn 400 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125734Lantidradonislecel-jujn351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LANTIDRADONISLECELCellTrans Inc.24610d9f-0c5a-4f55-93b3-d456300bfd5d2026-01-13Warnings, Adverse reactionsExact identifier
rxcui: 2642264

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
24610d9f-0c5a-4f55-93b3-d456300bfd5ddonislecel-jujn 400 ML InjectionPSN3These highlights do not include all the information needed to use LANTIDRA safely and effectively. See full prescribing information for LANTIDRA. LANTIDRA (donislecel-jujn) Suspension for hepatic portal vein infusion Initial U.S. Approval: 202320260113
24610d9f-0c5a-4f55-93b3-d456300bfd5d400 ML donislecel-jujn 2500 EIN/ML InjectionSCD3These highlights do not include all the information needed to use LANTIDRA safely and effectively. See full prescribing information for LANTIDRA. LANTIDRA (donislecel-jujn) Suspension for hepatic portal vein infusion Initial U.S. Approval: 202320260113
24610d9f-0c5a-4f55-93b3-d456300bfd5ddonislecel-jujn 400 ML InjectionSY3These highlights do not include all the information needed to use LANTIDRA safely and effectively. See full prescribing information for LANTIDRA. LANTIDRA (donislecel-jujn) Suspension for hepatic portal vein infusion Initial U.S. Approval: 202320260113